Looking at Q1, Amgen (NASDAQ:AMGN) earned $2.13 billion, a 6.03% increase from the preceding quarter. Amgen’s sales decreased to $5.90 billion, a 11.05% change since Q4. In Q4…
Return On Capital Employed Overview: Amgen
2021-04-28T15:32:56-04:00April 28th, 2021|